Literature DB >> 16962833

Determination of plasma thiol bound to albumin using affinity chromatography and high-performance liquid chromatography with fluorescence detection: ratio of cysteinyl albumin as a possible biomarker of oxidative stress.

Yuki Ogasawara1, Yoshio Mukai, Tadayasu Togawa, Toshihiro Suzuki, Shinzo Tanabe, Kazuyuki Ishii.   

Abstract

We examined the influence of oxidative stress on the relative amounts of various albumin-bound thiols in human plasma. To determine the ratio of thiols existing as mixed disulfides following oxidation, we developed a method combining fast purification of albumin using affinity columns and high-performance liquid chromatography (HPLC) with fluorescence detection for low molecular weight thiols which were labeled after reduction. When the effect of exposure of plasma to radical oxygen species on binding of thiols to albumin was determined by the present method, significant increases in the ratio of cysteine bound to albumin (Alb-Cys) to total cysteine were clearly demonstrated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962833     DOI: 10.1016/j.jchromb.2006.08.006

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  17 in total

Review 1.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

2.  2-fluoro-5-maleimidobenzoic acid-linked albumin drug (MAD) delivery for selective systemic targeting of metastatic prostate cancer.

Authors:  Emmanuel S Akinboye; Oliver C Rogers; John T Isaacs
Journal:  Prostate       Date:  2018-03-24       Impact factor: 4.104

3.  A simple colorimetric assay to determine the concentration and proportion of human mercaptalbumin.

Authors:  Sawaki Tada; Keiko Yasukawa; Yutaka Yatomi; Tomoaki Uchiki
Journal:  Pract Lab Med       Date:  2022-05-23

4.  Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.

Authors:  Yogita Ghodke-Puranik; Amrutesh S Puranik; Pooja Shintre; Kalpana Joshi; Bhushan Patwardhan; Jatinder Lamba; Timothy B Niewold; Arvind Chopra
Journal:  Pharmacogenomics       Date:  2015-11-30       Impact factor: 2.533

5.  Enrichment of cysteinyl adducts of human serum albumin.

Authors:  William E Funk; He Li; Anthony T Iavarone; Evan R Williams; Jacques Riby; Stephen M Rappaport
Journal:  Anal Biochem       Date:  2010-01-13       Impact factor: 3.365

6.  Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.

Authors:  Daniela Braconi; Claretta Bianchini; Giulia Bernardini; Marcella Laschi; Lia Millucci; Adriano Spreafico; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2011-08-27       Impact factor: 4.982

7.  Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques.

Authors:  Antonio Junior Lepedda; Angelo Zinellu; Gabriele Nieddu; Elisabetta Zinellu; Ciriaco Carru; Rita Spirito; Anna Guarino; Pierina De Muro; Marilena Formato
Journal:  Oxid Med Cell Longev       Date:  2013-02-04       Impact factor: 6.543

8.  Cassia auriculata: Aspects of Safety Pharmacology and Drug Interaction.

Authors:  Amrutesh S Puranik; Ganesh Halade; Sandeep Kumar; Ranjan Mogre; Kishori Apte; Ashok D B Vaidya; Bhushan Patwardhan
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-03       Impact factor: 2.629

Review 9.  Thiol reactive probes and chemosensors.

Authors:  Hanjing Peng; Weixuan Chen; Yunfeng Cheng; Lovemore Hakuna; Robert Strongin; Binghe Wang
Journal:  Sensors (Basel)       Date:  2012-11-19       Impact factor: 3.576

10.  Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings.

Authors:  R Rossi; D Giustarini; A Milzani; I Dalle-Donne
Journal:  J Cell Mol Med       Date:  2008-06-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.